Novel curcumin derivative CNB-001 mitigates obesity-associated insulin resistance

Author(s): Panzhinskiy E, Hua Y, Lapchak PA, Topchiy E, Lehmann TE, et al.


Type 2 diabetes is growing at epidemic proportions, and pharmacological interventions are being actively sought. This study examined the effect of a novel neuroprotective curcuminoid, CNB-001 [4-((1E)-2-(5-(4-hydroxy-3-methoxystyryl-)-1-phenyl-1H-pyrazoyl-3-yl)vinyl)-2-methoxy-phenol], on glucose intolerance and insulin signaling in high-fat diet (HFD)-fed mice. C57BL6 mice (5-6 weeks old) were randomly assigned to receive either a HFD (45% fat) or a low-fat diet (LFD, 10% fat) for 24 weeks, together with CNB-001 (40 mg/kg i.p. per day). Glucose tolerance test revealed that the area under the curve of postchallenge glucose concentration was elevated on HF-feeding, which was attenuated by CNB-001. CNB-001 attenuated body weight gain, serum triglycerides, and IL-6, and augmented insulin signaling [elevated phosphoprotein kinase B (p-Akt), and phosphoinsulin receptor (p-IR)β, lowered endoplasmic reticulum (ER) stress, protein-tyrosine phosphatase 1B (PTP1B)] and glucose uptake in gastrocnemius muscle of HFD-fed mice. Respiratory quotient, measured using a metabolic chamber, was elevated in HFD-fed mice, which was unaltered by CNB-001, although CNB-001 treatment resulted in higher energy expenditure. In cultured myotubes, CNB-001 reversed palmitate-induced impairment of insulin signaling and glucose uptake. Docking studies suggest a potential interaction between CNB-001 and PTP1B. Taken together, CNB-001 alleviates obesity-induced glucose intolerance and represents a potential candidate for further development as an antidiabetic agent.

Similar Articles

Modulation of 5-lipoxygenase in proteotoxicity and Alzheimer's disease

Author(s): Valera E, Dargusch R, Maher PA, Schubert D

A broadly neuroprotective derivative of curcumin

Author(s): Liu Y, Dargusch R, Maher P, Schubert D

Suppressive effects of a pyrazole derivative of curcumin on airway inflammation and remodeling

Author(s): Narumoto O, Matsuo Y, Sakaguchi M, Shoji S, Yamashita N, et al.

Neurovascular injury in acute hyperglycemia and diabetes: A comparative analysis in experimental stroke

Author(s): Elgebaly MM, Ogbi S, Li W, Mezzetti EM, Prakash R, et al.

The science of stroke: mechanisms in search of treatments

Author(s): Moskowitz MA, Lo EH, Iadecola C

Design, synthesis and insulin-sensitising effects of novel PTP1B inhibitors

Author(s): Tang YB, Lu D, Chen Z, Hu C, Yang Y, et al.

Discovery of novel PTP1B inhibitors with antihyperglycemic activity

Author(s): Liu Z, Chai Q, Li YY, Shen Q, Ma LP, et al.

Suramin derivatives as inhibitors and activators of protein-tyrosine phosphatases

Author(s): McCain DF, Wu L, Nickel P, Kassack MU, Kreimeyer A, et al.